AI-generated
May 3, 2026, 10:30
A New Era in Hemophilia A Prophylaxis – NEJM
The New England Journal of Medicine (NEJM) shared a post on X about a recent article by Maria Elisa Mancuso et al., adding:
”Original Article: Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without Inhibitors (phase 3 FRONTIER2 trial)
Science behind the Study: A Second Factor VIIIa Mimetic for Hemophilia A.”
Title: Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without Inhibitors
Authors: Maria Elisa Mancuso, Anthony K.C. Chan, Chandrakala Shanmukhaiah, Chuhl Joo Lyu, Joanna Zdziarska, Johnny Mahlangu, Lize F.D. van Vulpen, Pratima Chowdary, Renchi Yang, Steven R. Lentz, Tadashi Matsushita, Wan Hui Ong Clausen, Ilgiz Rakhmatullin, Johannes Oldenburg
Stay updated on all scientific advances with Hemostasis Today.
Anthony K C Chan
Chandrakala Shanmukhaiah
Chuhl Joo Lyu
Health
Hematology
Hemostasis
Hemostasis News
Hemostasis Today
Ilgiz Rakhmatullin
Joanna Zdziarska
Johannes Oldenburg
Johnny Mahlangu
Lize F.D. van Vulpen
Maria Elisa Mancuso
Medicine
NEJM
Pratima Chowdary
Renchi Yang
Steven R. Lentz
Tadashi Matsushita
Wan Hui Ong Clausen
-
Aug 11, 2026, 08:20Hasan Abbas Zaheer: Strengthening Universal Access to Safe Blood in Pakistan
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda